Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate

Publisher DOI
PubMed ID
22333403
Description
The NOCTET (NOrdic Certican Trial in HEart and lung Transplantation) trial demonstrated that everolimus improves renal function in maintenance thoracic transplant (TTx) recipients. Nevertheless, introduction of everolimus is not recommended for patients with advanced renal failure. We evaluated NOCTET data to assess everolimus introduction amongst TTx recipients with advanced renal failure.
Date of Publication
2012
Publication Type
Article
Language(s)
en
Contributor(s)
Arora, Satish
Gude, Einar
Mortensen, Svend Aage
Eiskjær, Hans
Riise, Gerdt
Mared, Lena
Bjørtuft, Oystein
Ekmehag, Bjørn
Jansson, Kjell
Simonsen, Svein
Aukrust, Pål
Solbu, Dag
Iversen, Martin
Gullestad, Lars
Additional Credits
Series
Journal of heart and lung transplantation
Publisher
Elsevier
ISSN
1053-2498
Access(Rights)
metadata.only
Show full item